Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.715 USD | +6.52% |
|
+28.20% | -48.80% |
Jul. 02 | Coherus BioSciences Grants Apotex License to Distribute Toripalimab in Canada | MT |
Jul. 02 | Coherus BioSciences, Inc. Enters into an Exclusive License and Distribution Agreement Apotex, Inc | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.80% | 185M | |
+21.88% | 127B | |
+24.57% | 117B | |
+26.99% | 27.77B | |
-17.80% | 20.44B | |
-14.64% | 16.62B | |
-13.15% | 15.92B | |
-46.65% | 14.94B | |
+12.80% | 14.74B | |
+57.12% | 14.38B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Transcript : Coherus Biosciences, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 09